関連する実験動画
Updated: Sep 10, 2025
04:05
Author Spotlight: Developing a Rat Model for Pouchitis Research and Treatment
Published on: May 31, 2024
475
急性重症潰瘍性大腸炎における救助療法とコレクトミーの早期予測要因
Samuel Jun Ming Lim1, Kaina Chen1, Yi Yuan Tan1
1Department of Gastroenterology and Hepatology, Singapore General Hospital, Singapore.
Singapore medical journal
|August 20, 2025
まとめ
急性重症潰瘍性大腸炎 (ASUC) の治療反応を予測する要因が特定されました. C反応性タンパク質 (CRP) とCRP- アルブミンの比率はステロイド耐性疾患のリスクを示し,低アルブミニアはコレクトミーリスクが高いことを示します.
科学分野:
- 胃腸内科
- 炎症性腸疾患の研究
- 臨床バイオマーカーの分析
背景:
- 急性重症潰瘍性大腸炎 (ASUC) は著しい罹病率を示しています.
- 約3分の1のASUC患者はステロイド治療に耐性がある.
- 救命療法に反応しない患者には,小腸切除が必要である.
研究 の 目的:
- ASUC患者における救助療法とコレクトミーの予測要因を特定する.
- 入院後24時間以内に早期のリスクの分層化を可能にします.
- ステロイド耐性ASUCの管理戦略を改善する.
主な方法:
- 58人のASUC入院者 (47人の患者) を対象とした遡及コホート研究.
- 入院時に測定された血清バイオマーカー (2002年8月~2022年1月)
- 1年以内に救助療法とコレクトミーが必要.
主要な成果:
- C反応性タンパク質 (CRP) が30mg/ L以上で,CRPアルブミン比率が0. 85以上で,救命療法が予測される.
- CRP > 30 mg/ Lと60歳以上の複合体では,救済療法のリスクが増加します.
- 低アルブミン血症 ≤25g/ Lおよび以前の生物学的使用はコレクトミーと関連していました.
- CRP ≥80 mg/ Lはコレクトミーに対する保護効果を示した.
結論:
- 摂取量の高いCRPまたはCRP- アルブミン比は,ステロイド耐性ASUCのリスクを示唆する.
- 低アルブミニアと以前の生物学的使用は,1年以内にコレクトミーを予測します.
- これらの予測要因を早期に特定することで 治療の決定を導くことができます
関連する概念動画
01:21Inflammatory Bowel Disease V: Surgical Management
212
Surgical interventions for inflammatory bowel disease (IBD), which includes ulcerative colitis and Crohn's disease, are essential in managing symptoms and addressing complications. The selection of surgical procedures is contingent upon the specific conditions and complications that stem from these illnesses.
Here are some common surgical interventions for IBD:
Here are some common surgical interventions for IBD:
212
01:29Drugs for Treatment of Ulcerative Colitis in IBD
236
Ulcerative colitis is a chronic inflammatory condition primarily affecting the colon and rectum. The primary drugs used in the treatment of ulcerative colitis are aminosalicylates. They exhibit anti-inflammatory and immunosuppressive properties. They modulate inflammatory mediators and inhibit the activity of nuclear factor κB (NF-κB). Aminosalicylates also reduce inflammation by inhibiting prostaglandin and leukotriene production and decreasing neutrophil chemotaxis and superoxide...
236
01:30Inflammatory Bowel Disease III: Diagnostic Studies and Management I-Nutritional Therapy
419
Various diagnostic tests are employed in the diagnostic process for Inflammatory Bowel Disease (IBD), particularly to differentiate between Crohn's disease and ulcerative colitis.
Diagnostic studies
A colonoscopy is the definitive screening test, distinguishing ulcerative colitis from other colon diseases with similar symptoms. During a colonoscopy test, inflamed mucosa with exudate ulcerations can be observed, and biopsies are taken to determine the histologic characteristics of the...
Diagnostic studies
A colonoscopy is the definitive screening test, distinguishing ulcerative colitis from other colon diseases with similar symptoms. During a colonoscopy test, inflamed mucosa with exudate ulcerations can be observed, and biopsies are taken to determine the histologic characteristics of the...
419
01:27Inflammatory Bowel Disease I: Ulcerative Colitis
321
Introduction
Inflammatory bowel disease, or IBD, encompasses a group of disorders characterized by chronic inflammation or ulceration of the gastrointestinal tract.
Risk Factors
The exact cause of IBD remains unclear, although it is believed to be due to a mix of genetic, environmental, microbial, and immune factors. Genetic factors are significant in determining susceptibility to IBD, with family history being a critical risk factor. Individuals with a first-degree relative who has IBD are at...
Inflammatory bowel disease, or IBD, encompasses a group of disorders characterized by chronic inflammation or ulceration of the gastrointestinal tract.
Risk Factors
The exact cause of IBD remains unclear, although it is believed to be due to a mix of genetic, environmental, microbial, and immune factors. Genetic factors are significant in determining susceptibility to IBD, with family history being a critical risk factor. Individuals with a first-degree relative who has IBD are at...
321
01:29Appendicitis-II: Diagnostic Studies and Management
145
Diagnosing and managing appendicitis requires a structured and comprehensive approach that spans from initial assessment to postoperative care. Here is an overview of the process:
Diagnosing Appendicitis
It requires a multifaceted approach, starting with a detailed physical examination to pinpoint the location and nature of the pain and identify any associated symptoms. Laboratory tests play a crucial role. A complete Blood Count (CBC) typically reveals leukocytosis (an increased number of...
Diagnosing Appendicitis
It requires a multifaceted approach, starting with a detailed physical examination to pinpoint the location and nature of the pain and identify any associated symptoms. Laboratory tests play a crucial role. A complete Blood Count (CBC) typically reveals leukocytosis (an increased number of...
145
01:26Endoscopic Procedures IV: Sigmoidoscopy and Laproscopy
171
Sigmoidoscopy and laparoscopy are distinct medical procedures that enable physicians to internally inspect different parts of the GI tract. Although they serve different purposes, each is essential for diagnosing and, in some cases, treating various medical conditions.
Sigmoidoscopy
Sigmoidoscopy is a diagnostic procedure that uses a flexible sigmoidoscope equipped with a light source and camera to examine the rectum and sigmoid colon. The procedure involves inserting the tube through the anus...
Sigmoidoscopy
Sigmoidoscopy is a diagnostic procedure that uses a flexible sigmoidoscope equipped with a light source and camera to examine the rectum and sigmoid colon. The procedure involves inserting the tube through the anus...
171